Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.64 USD | -.--% | -2.94% | -61.60% |
05-30 | SAB Biotherapeutics, Inc. Announces Change of Chief Financial Officer | CI |
05-21 | FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
24.36M | - | - | - | - | ||
118B | ||||||
106B | ||||||
24.28B | - | |||||
21.96B | - | |||||
18.16B |